VivoPower PLC (VIVO), a London-based B Corp-certified developer and owner of powered land and data-center infrastructure for AI compute applications, saw its shares plunge in Tuesday's session after the company released full-year financial results that sharply disappointed investors. The stock tumbled roughly 31% to around $1.52, down from a prior close of $2.21, as markets reacted to a widening loss and minimal revenue tied to its flagship AI data-center pivot.
The move was squarely earnings-driven. For the fiscal year ended June 30, 2026, VivoPower reported a loss from continuing operations of $50.4 million, a steep deterioration from a restated loss of $17.3 million in fiscal 2025. Total revenue came in at just $2.6 million, primarily reflecting a partial-period consolidation of the Mo i Rana Data Center in Norway, which was only included in results from May 12, 2026.
The loss was inflated by substantial non-cash charges, including $13.1 million in share-based payment expense and $14.8 million in fair-value losses on derivatives, warrants, and other investments. Adjusted EBITDA from continuing operations was negative $24.4 million. The magnitude of the shortfall — and the thin revenue base underpinning it — triggered aggressive selling as investors reassessed the company's path toward profitability.
A key source of investor disappointment was the composition of the data-center revenue. Over the roughly 50-day consolidation period, the Mo i Rana facility generated $2.5 million in revenue from bitcoin mining hosting rather than from the AI compute leases that have underpinned the company's repositioning story. That detail undercut the premium investors had assigned to VIVO as an emerging AI-infrastructure play and amplified the negative market reaction.
Compounding the bearish tone, VivoPower disclosed that its internal controls over financial reporting were deemed ineffective as of June 30, 2026, citing material weaknesses. Such disclosures tend to weigh on sentiment for small-cap companies, adding a governance-related overhang to an already weak fundamental update. The company also confirmed its electric-vehicles segment, operated through Tembo, remains a non-core business with a proposed combination still pending approvals.
The decline extended a multi-week slide. The stock has fallen sharply from levels above $3.00 in early October and trades well below both its 50-day and 200-day moving averages, reflecting sustained selling pressure in a speculative small-cap name. With a market capitalization of roughly $70 million and a 52-week range spanning $1.20 to $6.86, VIVO remains highly volatile, and Tuesday's move was among the sharpest single-session declines in its recent history as investors rushed to exit positions following the results.
Looking ahead, the market's focus shifts to execution. VivoPower has said it is finalizing terms with a prospective AI compute tenant for Mo i Rana and is evaluating financing options for a planned 40-megawatt conversion phase, with estimated capital expenditure of approximately $411 million. Investors will also monitor the pending Tembo business combination and any progress toward remediating the identified material weaknesses.
Risks remain substantial. The company continues to generate losses, relies heavily on external financing, and faces meaningful execution and dilution risks as it attempts to fund its AI-infrastructure buildout. Until there is clearer evidence of contracted AI lease revenue and a credible path to positive cash flow, shares are likely to remain under pressure.
Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a range of systematic approaches to consider. Explore Trending AI Robots to see which automated strategies are currently leading the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 42 cases where VIVO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VIVO's RSI Oscillator exited the oversold zone, 30 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 64 cases where VIVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on VIVO as a result. In 67 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for VIVO just turned positive on October 27, 2026. Looking at past instances where VIVO's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.
Following a +15.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 186 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.192) is normal, around the industry mean (16.593). P/E Ratio (-1.148) is within average values for comparable stocks, (57.337). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.283) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of diagnostic products
Industry ComputerCommunications